X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (529) 529
humans (477) 477
animals (389) 389
quinazolinones - pharmacology (312) 312
quinazolinones - therapeutic use (282) 282
male (229) 229
quinazolinones (171) 171
female (160) 160
mice (151) 151
chemistry, medicinal (146) 146
pharmacology & pharmacy (136) 136
quinazolinones - chemistry (126) 126
oncology (125) 125
rats (112) 112
quinazolines - therapeutic use (111) 111
purines - therapeutic use (107) 107
antineoplastic agents - therapeutic use (106) 106
cell line, tumor (93) 93
analysis (91) 91
leukemia, lymphocytic, chronic, b-cell - drug therapy (91) 91
apoptosis (84) 84
quinazolinones - administration & dosage (83) 83
derivatives (82) 82
antineoplastic agents - pharmacology (81) 81
cancer (80) 80
structure-activity relationship (74) 74
biochemistry & molecular biology (73) 73
inhibitors (72) 72
quinazolinone (72) 72
quinazolinones - chemical synthesis (72) 72
quinazolines - pharmacology (71) 71
chemistry, organic (70) 70
middle aged (70) 70
quinazolinones - adverse effects (66) 66
cell biology (64) 64
piperidines - pharmacology (62) 62
inhibition (61) 61
treatment outcome (61) 61
protein kinase inhibitors - therapeutic use (60) 60
purines - pharmacology (60) 60
dose-response relationship, drug (59) 59
piperidines (59) 59
article (58) 58
adult (57) 57
apoptosis - drug effects (57) 57
idelalisib (57) 57
piperidines - therapeutic use (57) 57
hematology (56) 56
disease models, animal (55) 55
halofuginone (55) 55
chronic lymphocytic-leukemia (53) 53
mutation (53) 53
activation (52) 52
aged (52) 52
cell proliferation - drug effects (52) 52
signal transduction - drug effects (52) 52
care and treatment (51) 51
molecular structure (50) 50
proteins (50) 50
rats, sprague-dawley (49) 49
inhibitor (47) 47
antineoplastic combined chemotherapy protocols - therapeutic use (46) 46
expression (45) 45
pyrimidines - therapeutic use (43) 43
antineoplastic agents (42) 42
cell survival - drug effects (42) 42
signal transduction (42) 42
biological evaluation (41) 41
chemistry, multidisciplinary (41) 41
chemotherapy (41) 41
pyrazoles - therapeutic use (40) 40
research (40) 40
drug design (39) 39
fibrosis (39) 39
rituximab (39) 39
antimitotic agents (38) 38
clinical trials as topic (38) 38
in-vitro (38) 38
pharmacology/toxicology (38) 38
abridged index medicus (37) 37
agents (37) 37
health aspects (37) 37
phosphorylation (37) 37
purines - adverse effects (37) 37
quinazolines - chemistry (36) 36
quinazolinones - pharmacokinetics (36) 36
rats, wistar (36) 36
sulfonamides - therapeutic use (36) 36
design (35) 35
phosphatidylinositol 3-kinases - antagonists & inhibitors (35) 35
purines - administration & dosage (35) 35
antineoplastic agents - adverse effects (34) 34
discovery (34) 34
enzyme inhibitors - pharmacology (34) 34
synthesis (34) 34
biomedicine (33) 33
drugs (33) 33
leukemia (33) 33
mice, inbred c57bl (33) 33
protein kinase inhibitors - pharmacology (33) 33
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (829) 829
German (7) 7
Japanese (7) 7
Spanish (3) 3
Chinese (2) 2
Danish (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 03/2014, Volume 370, Issue 11, pp. 1008 - 1018
Journal Article
Expert Review of Neurotherapeutics, ISSN 1473-7175, 02/2016, Volume 16, Issue 2, pp. 131 - 144
Adult Attention Deficit Hyperactivity Disorder (ADHD) is a prevalent psychiatric condition associated with high disability and frequent comorbidity. Current... 
Antidepressants | Attention Deficit Hyperactivity Disorder (ADHD) | Amphetamines | Efficacy | Lithium | Adults | Pharmacological Treatment | Metadoxine | ALZHEIMERS-DISEASE | BUPROPION TREATMENT | DEFICIT-HYPERACTIVITY DISORDER | CLINICAL NEUROLOGY | ATTENTION-DEFICIT/HYPERACTIVITY DISORDER | MIXED AMPHETAMINE SALTS | RESPONSE-INHIBITION | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | LISDEXAMFETAMINE DIMESYLATE | RECEPTOR AGONIST | METADOXINE EXTENDED-RELEASE | Humans | Paroxetine - therapeutic use | Venlafaxine Hydrochloride - therapeutic use | Dopamine Agents - therapeutic use | Droxidopa - therapeutic use | Pyrrolidonecarboxylic Acid - therapeutic use | Adrenergic alpha-Agonists - therapeutic use | Histamine Agents - therapeutic use | Central Nervous System Stimulants - therapeutic use | Desipramine - therapeutic use | Bridged Bicyclo Compounds, Heterocyclic - therapeutic use | Pyridoxine - therapeutic use | Adult | Lobeline - therapeutic use | Benzhydryl Compounds - therapeutic use | Nomifensine - therapeutic use | Morpholines - therapeutic use | Bupropion - therapeutic use | Pyridines - therapeutic use | Wakefulness-Promoting Agents - therapeutic use | Duloxetine Hydrochloride - therapeutic use | Guanfacine - therapeutic use | Nicotinic Agonists - therapeutic use | Attention Deficit Disorder with Hyperactivity - drug therapy | Antidepressive Agents - therapeutic use | Mecamylamine - therapeutic use | Amphetamines - therapeutic use | Lithium Compounds - therapeutic use | Lisdexamfetamine Dimesylate - therapeutic use | Nicotinic Antagonists - therapeutic use | Quinazolinones - therapeutic use | Memantine - therapeutic use | Drug Combinations
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2014, Volume 370, Issue 11, pp. 997 - 1007
Journal Article
Blood, ISSN 0006-4971, 07/2016, Volume 128, Issue 3, pp. 325 - 330
Journal Article
Blood, ISSN 0006-4971, 05/2014, Volume 123, Issue 22, pp. 3390 - 3397
Journal Article
Clinical Lymphoma, Myeloma & Leukemia, ISSN 2152-2650, 2015, Volume 15, Issue 6, pp. 314 - 322
Journal Article
The Lancet, ISSN 0140-6736, 04/2018, Volume 391, Issue 10129, pp. 1524 - 1537
Important advances in understanding the pathogenesis of chronic lymphocytic leukaemia in the past two decades have led to the development of new prognostic... 
MEDICINE, GENERAL & INTERNAL | PHASE-II TRIAL | FLUDARABINE PLUS CYCLOPHOSPHAMIDE | INTERNATIONAL PROGNOSTIC INDEX | PROGRESSION-FREE SURVIVAL | HIGH-RISK | BIWEEKLY CHLORAMBUCIL TREATMENT | OPEN-LABEL | STEM-CELL TRANSPLANTATION | SERUM THYMIDINE KINASE | PREVIOUSLY UNTREATED PATIENTS | Recurrence | Diagnosis, Differential | Genetic Predisposition to Disease | Pyrazoles - therapeutic use | Prognosis | Humans | Risk Factors | Leukemia, Lymphocytic, Chronic, B-Cell - etiology | Treatment Outcome | Leukemia, Lymphocytic, Chronic, B-Cell - genetics | Sulfonamides - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Bridged Bicyclo Compounds, Heterocyclic - therapeutic use | Pyrimidines - therapeutic use | Survival Analysis | Purines - therapeutic use | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Mutation | Quinazolinones - therapeutic use | Leukemia, Lymphocytic, Chronic, B-Cell - diagnosis | Monoclonal antibodies | Medical colleges | Chemotherapy | Cancer | Developed countries | Lymphatic system | Immunoglobulins | Chronic lymphatic leukemia | Bcl-2 protein | Laboratories | Research funding | Pathogenesis | Leukemia | Genes | Medical services | Family medical history | Disease control | Patients | Lymphocytes | Medical prognosis | CD20 antigen | Lymphomas | Evolution & development | Chromosomes | Age
Journal Article
Cancer Biology & Therapy, ISSN 1538-4047, 01/2014, Volume 15, Issue 1, pp. 3 - 9
Chemokines produced in distinct tissue microenvironments sustain migration of mature lymphocytes in lymphoglandula. Chemokine receptors expressed on chronic... 
microenvironment | targeted therapy | chemokines | chronic leukemia lymphoma | chemokines receptors | Chemokines receptors | Microenvironment | Targeted therapy | Chronic leukemia lymphoma | Chemokines | B-CELL RECEPTOR | SURVIVAL | ACTIVATION | PCI-32765 | PHASE-II | CXCR4 | IN-VITRO | ONCOLOGY | TYROSINE KINASE INHIBITOR | NODE MICROENVIRONMENT | GROWTH-FACTOR | Niacinamide - analogs & derivatives | Humans | Heterocyclic Compounds - pharmacology | Tumor Microenvironment | Antineoplastic Agents - therapeutic use | Thalidomide - pharmacology | Thiazoles - therapeutic use | Molecular Targeted Therapy | Thalidomide - analogs & derivatives | Antineoplastic Agents - pharmacology | Purines - therapeutic use | Quinazolinones - pharmacology | Oxazines - pharmacology | Pyridines - therapeutic use | Dasatinib | Purines - pharmacology | Receptors, CXCR4 - antagonists & inhibitors | Niacinamide - therapeutic use | Phenylurea Compounds - therapeutic use | Clinical Trials as Topic | Pyrimidines - pharmacology | Leukemia, Lymphocytic, Chronic, B-Cell - pathology | Receptors, CXCR4 - metabolism | Chemokine CXCL12 - metabolism | Oxazines - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Leukemia, Lymphocytic, Chronic, B-Cell - metabolism | Phenylurea Compounds - pharmacology | Protein Kinase Inhibitors - pharmacology | Pyridines - pharmacology | Thiazoles - pharmacology | Heterocyclic Compounds - therapeutic use | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Niacinamide - pharmacology | Quinazolinones - therapeutic use | Thalidomide - therapeutic use | Review
Journal Article
Journal Article